Phytoceuticals CE marks plant oil wound dressing
This article was originally published in Clinica
Executive Summary
Phytoceuticals, a firm specialising in medicines made from natural product extracts, has CE marked its 1 primary wound dressing for sale in Europe. The spray, which can be used for acute and chronic wounds, is made from a combination of two plant-derived oils, neem and St John's Wort. It acts as a physical barrier to prevent dessication or contamination, and prevents secondary dressings from sticking to the wound. Zurich, Switzerland-based Phytoceuticals claims that the plant oils also have a nourishing effect, supporting wound healing. The firm plans to make 1 available in Switzerland immediately, and eventually internationally, with the help of a "big industry partner".
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.